Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus-Reference-Cited by-同舟云学术

Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus

Published:2021-03 Issue: Volume:142 Page:14-24
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Wang Hao-Yu,Cai Zhong-Xing,Yin Dong,Yang Yue-Jin,Song Wei-Hua,Dou Ke-Fei^ORCID

Funder

Beijing Municipal Health Commission

Chinese College of Cardiovascular Physicians

National Key Research and Development Program of China

National Natural Science Foundation of China

Chinese Academy of Medical Sciences

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

2. Single or dual antiplatelet therapy after PCI;Miyazaki;Nat Rev Cardiol,2017

3. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;Mauri;New Eng J Med,2014

4. Benefits and risks of extended dual antiplatelet therapy after everolimus-eluting stents;Hermiller;JACC Cardiovasc Interv,2016

5. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) registry;Cavender;Circulation,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term clinical outcomes in elderly patients with chronic total occlusion and type 2 diabetes: the impact of coronary collateralization following successful recanalization;Cardiology Plus;2024-04

2. Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study;Frontiers in Cardiovascular Medicine;2023-04-06

3. Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent;Diabetes/Metabolism Research and Reviews;2022-04-22